Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease. Libiger O, Shaw LM, Watson MH, Nairn AC, et al. Alzheimers Dement 2021 May 13. doi: 10.1002/alz.12353.

Read + Share

Amedeo Smart

Independent Medical Education

Libiger O, Shaw LM, Watson MH, Nairn AC, et al. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease. Alzheimers Dement 2021 May 13. doi: 10.1002/alz.12353.
PMID: 33984181